Showing results (3751-3760 of 6,795) with videos related to
Sort By:
Pageof 680
Clinical Therapeutics|November 1, 1989
A controlled clinical trial of a new formulation of betamethasone dipropionate cream in once-daily treatment of psoriasisC N Ellis, H I Katz, I H Rex, et al.Clinical Therapeutics|April 27, 2016
Initial Experience With Tofacitinib in Clinical Practice: Treatment Patterns and Costs of Tofacitinib Administered as Monotherapy or in Combination With Conventional Synthetic DMARDs in 2 US Health Care Claims DatabasesJames Harnett, Jeffrey R Curtis, Robert Gerber, et al.Clinical Therapeutics|April 18, 2016
Safety, Pharmacokinetic, and Pharmacodynamic Evaluation After Single and Multiple Ascending Doses of a Novel Selective Androgen Receptor Modulator in Healthy SubjectsIndranil Bhattacharya, Sanela Tarabar, Yali Liang, et al.Clinical Therapeutics|December 3, 2014
Opioid interruptions, pain, and withdrawal symptoms in nursing home residentsSarah E Redding, Sophia Liu, William W Hung, et al.Clinical Therapeutics|December 3, 2014
Palliative care as a primary therapeutic approach in advanced dementia: a narrative reviewErin K Zahradnik, Hillel GrossmanClinical Therapeutics|December 3, 2014
Addressing depression in a long-term care setting: a phase II pilot of problem-solving treatmentJoann P Reinhardt, Amy Horowitz, Verena R Cimarolli, et al.Clinical Therapeutics|December 4, 2014
Pharmacokinetic interaction of finasteride with tamsulosin hydrochloride: an open-label, randomized, 3-period crossover study in healthy Chinese male volunteersNannan Chu, Hongrong Xu, Guoqin Wang, et al.Clinical Therapeutics|August 18, 2015
Patient and Physician Perspectives on Mode of Administration of the PCSK9 Monoclonal Antibody Alirocumab, an Injectable Medication to Lower LDL-C LevelsEli M Roth, Maja Bujas-Bobanovic, Michael J Louie, et al.Clinical Therapeutics|November 4, 2015
Relapses Requiring Intravenous Steroid Use and Multiple-Sclerosis-related Hospitalizations: Integrated Analysis of the Delayed-release Dimethyl Fumarate Phase III StudiesGavin Giovannoni, Ralf Gold, Robert J Fox, et al.Clinical Therapeutics|August 23, 2015
Expedited Programs for Serious Conditions: An Update on Breakthrough Therapy DesignationMartin Kwok, Theresa Foster, Michael SteinbergPageof 680